This course has expired. You can still review the content but course credit is no longer available.
Recent research suggests that the psychological effects of psoriasis are more complex than a simple response to living with a skin disease associated with stigma. Psychiatric conditions such as depression, anxiety, and suicidal ideation are now understood as comorbidities of psoriasis. This roundtable discussion brings together expert clinicians to discuss the psychological comorbidities of psoriasis. They also discuss how clinicians treating patients with psoriasis can screen for these comorbidities. The goal is to provide the best possible outcome for the whole patient.
This certified CME activity is designed for dermatologists, physician assistants, and nurse practitioners that treat patients with psoriasis.
Supported from an educational grant from Ortho Dermatologics, Inc.
Upon completion of this activity, the participant should be able to:
Evolve Medical Education LLC (Evolve) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
Evolve designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The following faculty/staff members have the following financial relationships with commercial interests:
Richard G. Fried, MD, PhD, has served as a Clinical Investigator: Eli Lilly, Foamix, Galderma, Incyte, Johnson and Johnson, Leo Pharma, Ortho Dermatologics, Photosonix , Regeneron Pharmaceuticals, SciaDerm, Sienna, Sun Pharmaceutical, and Topix. Consultant: Ortho Dermatologics and Sun Pharmaceutical.
Jashin J. Wu, M.D., has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: AbbVie, Almirall, Amgen, Bristol-Myers Squibb, Celgene, Dermira, Dr. Reddy’s Laboratories, Eli Lilly, Janssen, LEO Pharma, Novartis, Ortho Dermatologics, Promius Pharma, Regeneron Pharmaceuticals, Sun Pharmaceutical, and UCB. Grant/Research Support: AbbVie, Amgen, Eli Lilly, Janssen, and Novartis. Speaker’s Bureau: Celgene, Novartis, Sun Pharmaceutical, UCB, and Valeant Pharmaceuticals Intl/Ortho Dermatologics.
Editorial Support Disclosures
Erin K. Fletcher, MIT, director of compliance and education, Susan Gallagher-Pecha, director of client services and project management Evolve; and Kristen Richardson, writer have no financial relationships with commercial interests., Neil Shah, MD, peer reviewer, has no financial relationships with commercial interests.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Ortho Dermatologics.